Meropenem Injection
Product Images NDC 51810-503

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Meropenem (NDC 51810-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Antibiotics Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Meropenem 01)

Chemical Structure (Meropenem 01)
Chemical structure diagram of Meropenem, showing its molecular configuration with functional groups and hydration state (3 molecules of water).*
FDA Label Image

Image Description (Meropenem 1g Carton)

Image Description (Meropenem 1g Carton)
Packaging label for Meropenem injection, USP, 1 g per vial, for intravenous use only. The box contains 10 single-dose vials of 1 g each. The label prominently displays the product name, strength, and indicates it is for intravenous administration. The labeler is Qilu Antibiotics Pharmaceutical Co., Ltd. The design uses dark blue, white, and red colors with clear dosage information.*
FDA Label Image

Principal Display Panel (1 g Vial Label)

Principal Display Panel (1 g Vial Label)
Meropenem 1 g per vial injection label for intravenous use. The sterile single-dose vial contains meropenem equivalent to 1 g, manufactured by Qilu Antibiotics Pharmaceutical Co., Ltd. The label includes storage instructions, sodium content, and placeholders for lot number, expiration date, and GTIN information.*
FDA Label Image

Principal Display Panel (500 mg Vial Carton)

Principal Display Panel (500 mg Vial Carton)
Packaging label for Meropenem for Injection, USP, 500 mg per vial, meropenem equivalent. The label indicates the product is for intravenous use only and contains 10 single-dose vials of 500 mg each. The labeler is Qilu Antibiotics Pharmaceutical Co., Ltd.*
FDA Label Image

Principal Display Panel (500 mg Vial Label)

Principal Display Panel (500 mg Vial Label)
Meropenem for Injection, USP 500 mg/vial meropenem equivalent in a sterile single-dose vial for intravenous use. The label states the active ingredient amount, storage conditions, manufacturer Qilu Antibiotics Pharmaceutical Co., Ltd., and includes barcode and lot/expiration details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.